Infectious Enteritis Treatment Market
Global Infectious Enteritis Treatment Market Size, Share & Trends Analysis Report, by Type (Antibiotics, Antiviral, and Other), by Route of Administration (Oral and Injectable) and Forecast Period, 2019-2025
The global infectious enteritis treatment market is estimated to grow at a CAGR of around 4% during the forecast period. Infectious enteritis is an infection of the small intestine. Few major enteritis is caused by contaminated food and water which contains bacterial infection and viruses. A bacterial infection such as Campylobacter ejuni, Escherichia coli, toxigenic Clostridium difficile, and Vibrio cholera are some key causes of infectious disease or enteritis, commonly known as bacteremia. These infectious droplets lay down in small intestine which leads to swelling and infection in the small intestine. Moreover, these are the symptoms of enteritis including vomiting, nausea, fever, diarrhea, and others.
Apart from this, infectious enteritis is generally traced in developing nations due to a lack of healthcare facilities and awareness about a healthy lifestyle. However, the enteritis treatment including intravenous fluids and fluid or electrolyte rehydration. Chloramphenicol, Tertractcline, Ampicillin, Trimethoprim-sulfamethoxazole are been common anti-bacterial drugs used during the treatment. Moreover, due to technological advancement towards bacterial agents and the growing adoption of probiotics is expected to contribute to the global infectious enteritistreatment market.
Approval of treatment drugs by the US Food and Drug Administration (FDA) and a large number of manufactures encourage the growth rate of the infectious enteritis treatment market. Restrain factors such as the adverse effect of antibiotics and lack of awareness in underdeveloped nations hampers market growth. However, few opportunities lead the market to grow in the near future such as global expansion and an increase in product categories. Moreover, lowering down in production cost of drugs and provide qualitative products to their customers.
Segmentation
The global infectious enteritis treatment market is segmented based on the type and route of administration. Based on type, the market is classified into antibiotics, antiviral, and Other. Based on the route of administration, the market is classified into oral and injectable.
Antibiotics to have the highest market share in the infectious enteritis treatment market
Antibiotics have the highest market share in the market as it is used as the first line of treatment for infectious enteritis and ease of availability of products. The growing demand for effective drugs has fueled research and development of treatment drugs and a rise in approval by the FDA of manufacturing these drugs.
Global Infectious Enteritis Market Share by Type, 2018 (%)
Regional Outlook
Geographically, the global infectious enteritis treatment market is segmented into North America, Europe, Asia-Pacific, and the Rest of theWorld. North Americais estimated to witness a significant share in the market and is expected to retain its dominance in the coming years. In the US, an increase in infectious enteritis diseases such as diarrhea in the region. Moreover, due to intensive research and development to expand the product offering leads the market growth. Furthermore, Asia-Pacific is witnessing impressive growth in the market due to the rising number of patients and an increase in awareness among people. Higher disposable income and an increase in healthcare per capita are some of the factors that are also contributing the market growth.
Global Infectious Enteritis Market Growth, by Region 2019-2025
Competitive Landscape
The major companies operating in the market include Abbott Laboratories, Pfizer, Inc., Bristol-Myers Squibb Co., AstraZeneca PLC, F. Hoffmann-La Roche AG, GlaxoSmithKline, PLC, Novartis AG, and Teva Pharmaceuticals Industries, Ltd. These players are offering antibiotic drugs and focused on developing an effective antiviral drug for better outcomes.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global infectious enteritis treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Abbott Laboratories
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Bristol-Myers Squibb Co.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. GlaxoSmithKline, PLC
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. F. Hoffmann-La Roche AG
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Infectious Enteritis Treatment Market by Type
5.1.1. Antibiotics
5.1.2. Antiviral
5.1.3. Other (Intravenous (IV) Fluids)
5.2. Global Infectious Enteritis Treatment Market by Route of Administration
5.2.1. Oral
5.2.2. Injectable
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories
7.2. Actelion Pharmaceuticals, Ltd.
7.3. Apotex, Inc.
7.4. Aqua Pharmaceuticals, LLC
7.5. AstraZeneca PLC
7.6. BioGaia AB
7.7. Bristol-Myers Squibb Co.
7.8. F. Hoffmann-La Roche AG
7.9. GlaxoSmithKline, PLC
7.10. Lonza AG
7.11. Mylan N.V.
7.12. Novartis AG
7.13. Pfizer, Inc.
7.14. Teva Pharmaceuticals Industries, Ltd.
7.15. Valeant Pharmaceuticals International, Inc.
1. GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
2. GLOBAL ANTIBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL ANTIVIRAL MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL OTHER INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2015 ($ MILLION)
5. GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
6. GLOBAL ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL INJECTABLE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
9. NORTH AMERICAN INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
10. NORTH AMERICAN INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
11. NORTH AMERICAN INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
12. EUROPEAN INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
13. EUROPEAN INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
14. EUROPEAN INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
15. ASIA-PACIFIC INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
16. ASIA-PACIFIC INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
17. ASIA-PACIFIC INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
18. REST OF THE WORLD INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
19. REST OF THE WORLD INFECTIOUS ENTERITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2018-2025 ($ MILLION)
1. GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET SHARE BY ROUTE OF ADMINISTRATION, 2018 VS 2025 (%)
3. GLOBAL INFECTIOUS ENTERITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. US INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
5. CANADA INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
6. UK INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
7. FRANCE INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
8. GERMANY INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
9. ITALY INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
10. SPAIN INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
11. ROE INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
12. INDIA INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
13. CHINA INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
14. JAPAN INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF ASIA-PACIFIC INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF THE WORLD INFECTIOUS ENTERITIS TREATMENT MARKET SIZE, 2018-2025 ($ MILLION
